Cargando…

Structural basis of nanobodies neutralizing SARS-CoV-2 variants

Because of the evolutionary variants of SARS-CoV-2, development of broad-spectrum neutralizing antibodies resilient to virus escape is urgently needed. We identified a group of high-affinity nanobodies from camels immunized with receptor-binding domain (RBD) of SARS-CoV-2 spike protein and resolved...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shi, Zhenzhong, Li, Xiyang, Wang, Lu, Sun, Zengchao, Zhang, Haiwei, Chen, Xiaochen, Cui, Qianqian, Qiao, Huarui, Lan, Zhongyun, Zhang, Xin, Li, Xianheng, Li, Lingyun, Xu, Jianfeng, Gong, Rui, Fan, Chengpeng, Geng, Yong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8908544/ https://www.ncbi.nlm.nih.gov/pubmed/35276082 http://dx.doi.org/10.1016/j.str.2022.02.011

Ejemplares similares

An extended conformation of SARS-CoV-2 main protease reveals allosteric targets
por: Sun, Zengchao, et al.
Publicado: (2022)

Preparation and characterization of nanobodies targeting SARS-CoV-2 papain-like protease
por: Qiao, Huarui, et al.
Publicado: (2023)

A potent neutralizing nanobody against SARS‐CoV‐2 with inhaled delivery potential
por: Gai, Junwei, et al.
Publicado: (2021)

An ultrapotent RBD-targeted biparatopic nanobody neutralizes broad SARS-CoV-2 variants
por: Chi, Xiaojing, et al.
Publicado: (2022)

Nanobodies that Neutralize HIV
por: Weiss, Robin A., et al.
Publicado: (2019)

Development of a bispecific nanobody conjugate broadly neutralizes diverse SARS-CoV-2 variants and structural basis for its broad neutralization
por: Yang, Jing, et al.
Publicado: (2023)

CAMEL NANOBODIES NEUTRALIZE SARS-COV-2 VARIANTS
por: Hong, Jessica, et al.
Publicado: (2023)

Sensitivity-enhanced nanoplasmonic biosensor using direct immobilization of two engineered nanobodies for SARS-CoV-2 spike receptor-binding domain detection
por: Ma, Zhengtai, et al.
Publicado: (2023)

Camel nanobodies broadly neutralize SARS-CoV-2 variants
por: Hong, Jessica, et al.
Publicado: (2021)

Identification and characterization of blocking nanobodies against human CD70: Identification and characterization of blocking nanobodies
por: Zhang, Xin, et al.
Publicado: (2022)

Neutralization of Human Interleukin 23 by Multivalent Nanobodies Explained by the Structure of Cytokine–Nanobody Complex
por: Desmyter, Aline, et al.
Publicado: (2017)

The structural basis of nanobody unfolding reversibility and thermoresistance
por: Kunz, Patrick, et al.
Publicado: (2018)

Structural Basis of Nanobodies Targeting the Prototype Norovirus
por: Ruoff, Kerstin, et al.
Publicado: (2019)

Dromedary camel nanobodies broadly neutralize SARS-CoV-2 variants
por: Hong, Jessica, et al.
Publicado: (2022)

A Potent Neutralizing Nanobody Targeting the Spike Receptor-Binding Domain of SARS-CoV-2 and the Structural Basis of Its Intimate Binding
por: Yang, Jing, et al.
Publicado: (2022)

Identification of two novel neutralizing nanobodies against swine hepatitis E virus
por: Chen, Yiyang, et al.
Publicado: (2022)

Structural Characterization of a Neutralizing Nanobody With Broad Activity Against SARS-CoV-2 Variants
por: Li, Tingting, et al.
Publicado: (2022)

Accelerating PERx reaction enables covalent nanobodies for potent neutralization of SARS-CoV-2 and variants
por: Yu, Bingchen, et al.
Publicado: (2022)

Antibody–nanobody combination increases their neutralizing activity against SARS-CoV-2 and nanobody H11-H4 is effective against Alpha, Kappa and Delta variants
por: Nguyen, Hung, et al.
Publicado: (2022)

A cell-free nanobody engineering platform rapidly generates SARS-CoV-2 neutralizing nanobodies
por: Chen, Xun, et al.
Publicado: (2021)

Development of Thermally Stable Nanobodies for Detection and Neutralization of Staphylococcal Enterotoxin B
por: Hughes, Anna C., et al.
Publicado: (2023)

Versatile and multivalent nanobodies efficiently neutralize SARS-CoV-2
por: Xiang, Yufei, et al.
Publicado: (2020)

A potent alpaca-derived nanobody that neutralizes SARS-CoV-2 variants
por: Weinstein, Jules B., et al.
Publicado: (2022)

Nanobodies from camelid mice and llamas neutralize SARS-CoV-2 variants
por: Xu, Jianliang, et al.
Publicado: (2021)

Structural insights into the activation of human calcium-sensing receptor
por: Chen, Xiaochen, et al.
Publicado: (2021)

Prospects of Neutralizing Nanobodies Against SARS-CoV-2
por: Chen, Fangfang, et al.
Publicado: (2021)

Isolation of an escape-resistant SARS-CoV-2 neutralizing nanobody from a novel synthetic nanobody library
por: Dormeshkin, Dmitri, et al.
Publicado: (2022)

Physicochemical Characterization and Immunomodulatory Activity of a Novel Acid Polysaccharide from Solanum muricatum
por: Yue, Heng, et al.
Publicado: (2019)

Versatile, Multivalent Nanobody Cocktails Efficiently Neutralize SARS-CoV-2
por: Xiang, Yufei, et al.
Publicado: (2020)

Development of Neutralizing Nanobodies to the Hemagglutinin Stem Domain of Influenza A Viruses
por: Voronina, D. V., et al.
Publicado: (2021)

Structural basis of a novel PD-L1 nanobody for immune checkpoint blockade
por: Zhang, Fei, et al.
Publicado: (2017)

Structural basis of α(1A)-adrenergic receptor activation and recognition by an extracellular nanobody
por: Toyoda, Yosuke, et al.
Publicado: (2023)

Structural basis for the allosteric modulation of rhodopsin by nanobody binding to its extracellular domain
por: Wu, Arum, et al.
Publicado: (2023)

Isolation, characterization, and structure-based engineering of a neutralizing nanobody against SARS-CoV-2
por: Li, Tingting, et al.
Publicado: (2022)

Evaluation of SARS-CoV-2-Neutralizing Nanobody Using Virus Receptor Binding Domain-Administered Model Mice
por: Liu, Song, et al.
Publicado: (2022)

An ultrapotent synthetic nanobody neutralizes SARS-CoV-2 by stabilizing inactive Spike
por: Schoof, Michael, et al.
Publicado: (2020)

The Application of Nanobody in CAR-T Therapy
por: Bao, Chaolemeng, et al.
Publicado: (2021)

A Multivalent and Thermostable Nanobody Neutralizing SARS-CoV-2 Omicron (B.1.1.529)
por: Lu, Yuying, et al.
Publicado: (2023)

Nanobodies targeting norovirus capsid reveal functional epitopes and potential mechanisms of neutralization
por: Koromyslova, Anna D., et al.
Publicado: (2017)

An alpaca nanobody neutralizes SARS-CoV-2 by blocking receptor interaction
por: Hanke, Leo, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_rmcra7nr7et00bsusm29veqqkk